 | • レポートコード：B-GIR08C5645 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、全身性硬化症治療の世界市場について調べ、まとめました。種類別セグメントは、限局性皮膚全身性硬化症、びまん性皮膚全身性硬化症等、用途別セグメントは、等に区分しました。全身性硬化症治療の世界市場概観、企業動向、企業別全身性硬化症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・全身性硬化症治療の市場概観 ・全身性硬化症治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・全身性硬化症治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・全身性硬化症治療の世界市場規模 ・全身性硬化症治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・全身性硬化症治療のアメリカ市場規模推移 ・全身性硬化症治療のカナダ市場規模推移 ・全身性硬化症治療のメキシコ市場規模推移 ・全身性硬化症治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・全身性硬化症治療のドイツ市場規模推移 ・全身性硬化症治療のイギリス市場規模推移 ・全身性硬化症治療のロシア市場規模推移 ・全身性硬化症治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・全身性硬化症治療の日本市場規模推移 ・全身性硬化症治療の中国市場規模推移 ・全身性硬化症治療の韓国市場規模推移 ・全身性硬化症治療のインド市場規模推移 ・全身性硬化症治療の東南アジア市場規模推移 ・全身性硬化症治療の南米市場分析（ブラジル、アルゼンチン等） ・全身性硬化症治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・全身性硬化症治療の種類別分析/販売量、売上、市場シェア（限局性皮膚全身性硬化症、びまん性皮膚全身性硬化症） ・全身性硬化症治療の用途別分析/市場規模（） ・全身性硬化症治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・全身性硬化症治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Systemic sclerosis is a rare but serious autoimmune disease which causes hardening and swelling of the skin, as well as joint pain, digestive problems, lung disease, and sometimes problems with the heart and kidneys.
Scope of the Report:
The global Systemic Sclerosis Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Systemic Sclerosis Treatments.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Systemic Sclerosis Treatments market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Systemic Sclerosis Treatments market by product type and applications/end industries.
Market Segment by Companies, this report covers
Cytori Therapeutics
Actelion Pharmaceuticals
Boehringer Ingelheim
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Limited Cutaneous Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Market Segment by Applications, can be divided into
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Online Pharmacies
Table of Contents
1 Systemic Sclerosis Treatments Market Overview
1.1 Product Overview and Scope of Systemic Sclerosis Treatments
1.2 Classification of Systemic Sclerosis Treatments by Types
1.2.1 Global Systemic Sclerosis Treatments Revenue Comparison by Types (2019-2024)
1.2.2 Global Systemic Sclerosis Treatments Revenue Market Share by Types in 2018
1.2.3 Limited Cutaneous Systemic Sclerosis
1.2.4 Diffuse Cutaneous Systemic Sclerosis
1.3 Global Systemic Sclerosis Treatments Market by Application
1.3.1 Global Systemic Sclerosis Treatments Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.3.5 Online Pharmacies
1.4 Global Systemic Sclerosis Treatments Market by Regions
1.4.1 Global Systemic Sclerosis Treatments Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Systemic Sclerosis Treatments Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Systemic Sclerosis Treatments Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Systemic Sclerosis Treatments Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Systemic Sclerosis Treatments Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Systemic Sclerosis Treatments Status and Prospect (2014-2024)
1.5 Global Market Size of Systemic Sclerosis Treatments (2014-2024)
2 Manufacturers Profiles
2.1 Cytori Therapeutics
2.1.1 Business Overview
2.1.2 Systemic Sclerosis Treatments Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Cytori Therapeutics Systemic Sclerosis Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.2 Actelion Pharmaceuticals
2.2.1 Business Overview
2.2.2 Systemic Sclerosis Treatments Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Actelion Pharmaceuticals Systemic Sclerosis Treatments Revenue, Gross Margin and Market Share (2017-2018)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Systemic Sclerosis Treatments Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Systemic Sclerosis Treatments Revenue, Gross Margin and Market Share (2017-2018)
3 Global Systemic Sclerosis Treatments Market Competition, by Players
3.1 Global Systemic Sclerosis Treatments Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Systemic Sclerosis Treatments Players Market Share
3.2.2 Top 10 Systemic Sclerosis Treatments Players Market Share
3.3 Market Competition Trend
4 Global Systemic Sclerosis Treatments Market Size by Regions
4.1 Global Systemic Sclerosis Treatments Revenue and Market Share by Regions
4.2 North America Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
4.3 Europe Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
4.5 South America Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
5 North America Systemic Sclerosis Treatments Revenue by Countries
5.1 North America Systemic Sclerosis Treatments Revenue by Countries (2014-2019)
5.2 USA Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
5.3 Canada Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
5.4 Mexico Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
6 Europe Systemic Sclerosis Treatments Revenue by Countries
6.1 Europe Systemic Sclerosis Treatments Revenue by Countries (2014-2019)
6.2 Germany Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
6.3 UK Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
6.4 France Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
6.5 Russia Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
6.6 Italy Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Systemic Sclerosis Treatments Revenue by Countries
7.1 Asia-Pacific Systemic Sclerosis Treatments Revenue by Countries (2014-2019)
7.2 China Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
7.3 Japan Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
7.4 Korea Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
7.5 India Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
8 South America Systemic Sclerosis Treatments Revenue by Countries
8.1 South America Systemic Sclerosis Treatments Revenue by Countries (2014-2019)
8.2 Brazil Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
8.3 Argentina Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
8.4 Colombia Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Systemic Sclerosis Treatments by Countries
9.1 Middle East and Africa Systemic Sclerosis Treatments Revenue by Countries (2014-2019)
9.2 Saudi Arabia Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
9.3 UAE Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
9.4 Egypt Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
9.5 Nigeria Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
9.6 South Africa Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
10 Global Systemic Sclerosis Treatments Market Segment by Type
10.1 Global Systemic Sclerosis Treatments Revenue and Market Share by Type (2014-2019)
10.2 Global Systemic Sclerosis Treatments Market Forecast by Type (2019-2024)
10.3 Limited Cutaneous Systemic Sclerosis Revenue Growth Rate (2014-2024)
10.4 Diffuse Cutaneous Systemic Sclerosis Revenue Growth Rate (2014-2024)
11 Global Systemic Sclerosis Treatments Market Segment by Application
11.1 Global Systemic Sclerosis Treatments Revenue Market Share by Application (2014-2019)
11.2 Systemic Sclerosis Treatments Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Drug Stores Revenue Growth (2014-2019)
11.5 Retail Pharmacies Revenue Growth (2014-2019)
11.6 Online Pharmacies Revenue Growth (2014-2019)
12 Global Systemic Sclerosis Treatments Market Size Forecast (2019-2024)
12.1 Global Systemic Sclerosis Treatments Market Size Forecast (2019-2024)
12.2 Global Systemic Sclerosis Treatments Market Forecast by Regions (2019-2024)
12.3 North America Systemic Sclerosis Treatments Revenue Market Forecast (2019-2024)
12.4 Europe Systemic Sclerosis Treatments Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Systemic Sclerosis Treatments Revenue Market Forecast (2019-2024)
12.6 South America Systemic Sclerosis Treatments Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Systemic Sclerosis Treatments Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Systemic Sclerosis Treatments Picture
Table Product Specifications of Systemic Sclerosis Treatments
Table Global Systemic Sclerosis Treatments and Revenue (Million USD) Market Split by Product Type
Figure Global Systemic Sclerosis Treatments Revenue Market Share by Types in 2018
Figure Limited Cutaneous Systemic Sclerosis Picture
Figure Diffuse Cutaneous Systemic Sclerosis Picture
Table Global Systemic Sclerosis Treatments Revenue (Million USD) by Application (2014-2024)
Figure Systemic Sclerosis Treatments Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Drug Stores Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Systemic Sclerosis Treatments Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Systemic Sclerosis Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Systemic Sclerosis Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Systemic Sclerosis Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Systemic Sclerosis Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Systemic Sclerosis Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Systemic Sclerosis Treatments Revenue (Million USD) and Growth Rate (2014-2024)
Table Cytori Therapeutics Basic Information, Manufacturing Base and Competitors
Table Cytori Therapeutics Systemic Sclerosis Treatments Type and Applications
Table Cytori Therapeutics Systemic Sclerosis Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Actelion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Actelion Pharmaceuticals Systemic Sclerosis Treatments Type and Applications
Table Actelion Pharmaceuticals Systemic Sclerosis Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Systemic Sclerosis Treatments Type and Applications
Table Boehringer Ingelheim Systemic Sclerosis Treatments Revenue, Gross Margin and Market Share (2017-2018)
Table Global Systemic Sclerosis Treatments Revenue (Million USD) by Players (2014-2019)
Table Global Systemic Sclerosis Treatments Revenue Share by Players (2014-2019)
Figure Global Systemic Sclerosis Treatments Revenue Share by Players in 2017
Figure Global Systemic Sclerosis Treatments Revenue Share by Players in 2018
Figure Global Top 5 Players Systemic Sclerosis Treatments Revenue Market Share in 2018
Figure Global Top 10 Players Systemic Sclerosis Treatments Revenue Market Share in 2018
Figure Global Systemic Sclerosis Treatments Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Systemic Sclerosis Treatments Revenue (Million USD) by Regions (2014-2019)
Table Global Systemic Sclerosis Treatments Revenue Market Share by Regions (2014-2019)
Figure Global Systemic Sclerosis Treatments Revenue Market Share by Regions (2014-2019)
Figure Global Systemic Sclerosis Treatments Revenue Market Share by Regions in 2018
Figure North America Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Europe Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure South America Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Table North America Systemic Sclerosis Treatments Revenue by Countries (2014-2019)
Table North America Systemic Sclerosis Treatments Revenue Market Share by Countries (2014-2019)
Figure North America Systemic Sclerosis Treatments Revenue Market Share by Countries (2014-2019)
Figure North America Systemic Sclerosis Treatments Revenue Market Share by Countries in 2018
Figure USA Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Canada Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Mexico Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Table Europe Systemic Sclerosis Treatments Revenue (Million USD) by Countries (2014-2019)
Figure Europe Systemic Sclerosis Treatments Revenue Market Share by Countries (2014-2019)
Figure Europe Systemic Sclerosis Treatments Revenue Market Share by Countries in 2018
Figure Germany Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure UK Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure France Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Russia Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Italy Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Systemic Sclerosis Treatments Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Systemic Sclerosis Treatments Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Systemic Sclerosis Treatments Revenue Market Share by Countries in 2018
Figure China Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Japan Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Korea Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure India Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Table South America Systemic Sclerosis Treatments Revenue by Countries (2014-2019)
Table South America Systemic Sclerosis Treatments Revenue Market Share by Countries (2014-2019)
Figure South America Systemic Sclerosis Treatments Revenue Market Share by Countries (2014-2019)
Figure South America Systemic Sclerosis Treatments Revenue Market Share by Countries in 2018
Figure Brazil Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Argentina Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Colombia Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Systemic Sclerosis Treatments Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Systemic Sclerosis Treatments Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Systemic Sclerosis Treatments Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Systemic Sclerosis Treatments Revenue Market Share by Countries in 2018
Figure Saudi Arabia Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure UAE Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Egypt Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure Nigeria Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Figure South Africa Systemic Sclerosis Treatments Revenue and Growth Rate (2014-2019)
Table Global Systemic Sclerosis Treatments Revenue (Million USD) by Type (2014-2019)
Table Global Systemic Sclerosis Treatments Revenue Share by Type (2014-2019)
Figure Global Systemic Sclerosis Treatments Revenue Share by Type (2014-2019)
Figure Global Systemic Sclerosis Treatments Revenue Share by Type in 2018
Table Global Systemic Sclerosis Treatments Revenue Forecast by Type (2019-2024)
Figure Global Systemic Sclerosis Treatments Market Share Forecast by Type (2019-2024)
Figure Global Limited Cutaneous Systemic Sclerosis Revenue Growth Rate (2014-2019)
Figure Global Diffuse Cutaneous Systemic Sclerosis Revenue Growth Rate (2014-2019)
Table Global Systemic Sclerosis Treatments Revenue by Application (2014-2019)
Table Global Systemic Sclerosis Treatments Revenue Share by Application (2014-2019)
Figure Global Systemic Sclerosis Treatments Revenue Share by Application (2014-2019)
Figure Global Systemic Sclerosis Treatments Revenue Share by Application in 2018
Table Global Systemic Sclerosis Treatments Revenue Forecast by Application (2019-2024)
Figure Global Systemic Sclerosis Treatments Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Drug Stores Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Systemic Sclerosis Treatments Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Systemic Sclerosis Treatments Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Systemic Sclerosis Treatments Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Systemic Sclerosis Treatments Revenue Market Forecast (2019-2024)
Figure Europe Systemic Sclerosis Treatments Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Systemic Sclerosis Treatments Revenue Market Forecast (2019-2024)
Figure South America Systemic Sclerosis Treatments Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Systemic Sclerosis Treatments Revenue Market Forecast (2019-2024)
皮膚・全身性リーシュマニア症薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Cutaneous and Systemic Leishmaniasis is the most common syndrome and can produce ulcers that have the potential of stimulating a periosteal reaction if the ulcer occurs near bone. Scope of the Report: The global Cutaneous and Systemic Leishmaniasis Drugs market is valued at xx million USD in 2018 an…- 世界の全身性アスペルギルス症と全身性カンジダ症市場2019 The global Systemic Aspergillosis and Systemic Candidasis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Systemic Aspergillosis and Systemic Candidasis market status and forecast, categoriz…
- 次性進行型多発性硬化症（PPMS）治療剤市場：世界及び中国の市場分析・予測（～2024年） Primary Progressive Multiple Sclerosis Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Primary Progressive Multiple Sclerosis Treatment industry with a focus on the Chinese market. The report provides key statistics …
- 世界の進行性再発性多発性硬化症治療市場2019 The global Progressive Relapsing Multiple Sclerosis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Progressive Relapsing Multiple Sclerosis Treatment market status and forecast, c…
- 世界の全身口腔アゾール市場2019 The global Systemic Oral Azoles market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Systemic Oral Azoles market status and forecast, categorizes the global Systemic Oral Azoles market size (valu…